PanCryos Competitors and Similar CompaniesClear all

PanCryos's competitors and similar companies include Diabetology, Novo Nordisk, Kowa Pharmaceuticals America and Rezolute.

	PanCryos PanCryos is a company that aims to develop a stem cell-derived allogeneic cell therapy (PanINSULA) for type 1 diabetes.	Diabetology Diabetology is a clinical-stage biopharmaceutical company.	Novo Nordisk Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products.	Kowa Pharmaceuticals America Kowa Pharmaceuticals America is a pharmaceutical company focused on cardiometabolic diseases.	Rezolute Rezolute develops novel therapeutic products for the diabetes market.
Founding Date	Founding Date 2015	Founding Date 2003	Founding Date 1923	Founding Date 2008	Founding Date 2010
Type	Type Private	Type Private	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare diabetes pharma	Tags Healthcare diabetes drug development pharma	Tags Healthcare diabetes drug development pharma	Tags Healthcare biotech diabetes pharma	Tags Healthcare diabetes pharma platform
Locations	Locations København, DK HQ København, DK	Locations London, GB HQ Claremont, AU	Locations Bagsværd, DK HQ Tirana, AL Boufarik, DZ Hydra, DZ Tizi Ouzou, DZ Buenos Aires, AR North Sydney, AU see more	Locations Montgomery, US HQ	Locations Louisville, US HQ Bend, US Redwood City, US
Employees	Employees 2	Employees 8	Employees 77,406	Employees 3521% increase	Employees 195% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 599.3 b	Valuation ($) N/A	Valuation ($) 317.7 m
Financial
Net income	Net income N/A	Net income N/A	Net income kr102.4b (FY, 2025)	Net income N/A	Net income ($74.4m) (FY, 2025)